
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

Bacteriophages, or phages, offer a promising alternative to traditional antibiotics for managing multidrug-resistant pathogens. Recent research into phage therapy gut microbiota interactions suggests that these viral agents can selectively target bacteria like Salmonella. However, their impact on the broader microbial ecosystem remains a subject of intense study. In a new trial involving chickens, investigators explored how recurrent administration affects intestinal health and pathogen control.
Researchers conducted a study on eighty chicks to determine the efficacy of a six-phage cocktail against Salmonella Enteritidis. Interestingly, the results showed that continuous high-dose treatment actually resulted in higher colonization levels compared to short-term pre-infection exposure. This finding suggests that dosing schedules play a critical role in treatment success. Furthermore, the phage administration significantly altered alpha and beta diversities, particularly before the onset of the infection. These changes gradually diminished as the birds aged, indicating a time-dependent response to the treatment.
The analysis revealed that phage treatment induced modifications in both the composition and functional profile of the gut. Specifically, the phages promoted an oxygen-utilizing microbial community during the early stages. This shift may have inadvertently counteracted the protective effects of the treatment. By creating a niche that potentially favors certain metabolic pathways, the phages might have altered the competitive landscape of the gut. Consequently, these results emphasize the importance of considering dynamic microbial interactions when designing phage-based strategies.
Moreover, the study highlights that while phages are highly specific, they are not entirely neutral in their effect on the microbiome. The transient reshaping of the gut community suggests that phage therapy acts as a biological intervention with its own set of ecological consequences. Future strategies may need to combine phages with other modulators, such as probiotics, to maintain a stable and protective microbial environment. Ultimately, understanding these complex interactions is essential for advancing the clinical application of phage therapy in both veterinary and human medicine.
Surprisingly, the study found that continuous, high-dose phage treatment led to higher Salmonella colonization levels in chickens compared to those receiving only short-term exposure before infection.
Phage therapy significantly influenced both alpha and beta diversities of the gut microbiota. The most substantial changes occurred before the Salmonella challenge and tended to decrease over time.
The phage cocktail transiently altered the predicted functions of the microbiota, favoring an oxygen-utilizing community. Researchers believe this shift might have reduced the overall protective effect of the phages against the target pathogen.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Agapé L et al. Recurrent phage treatment of Salmonella-infected chickens transiently reshapes gut microbiota composition and function. Vet Res. 2026 Mar 14. doi: 10.1186/s13567-025-01708-4. PMID: 41832592.
Wang J et al. Combination of bacteriophage-probiotics alleviates intestinal barrier dysfunction by regulating gut microbiome in a chick model of multidrug-resistant Salmonella infection. J Anim Sci Biotechnol. 2026 Jan 23;17(1):14. doi: 10.1186/s40104-025-01324-4.
Hsu BB et al. Bacteriophages Synergize with the Gut Microbial Community To Combat Salmonella. mSystems. 2025; doi: 10.1128/mSystems.
"
A study on chickens found that recurrent phage treatment transiently reshapes gut microbiota and, surprisingly, may lead to higher Salmonella colonization....
3 months ago

A target trial emulation study within the Veterans Health Administration shows that starting CGM therapy is associated with a 10% to 16% reduction in all-cause mortality for older-onset type 1 diabetes patients, particularly those over 65 or not using insulin pumps.
Today

A large-scale retrospective study reveals a sharp rise in gestational and type 2 diabetes alongside severe maternal morbidity between 2016 and 2022. While gestational diabetes is most prevalent, type 1 diabetes poses the highest risk for maternal complications, necessitating multidisciplinary care.
Today

AI is transforming pediatric radiology by enhancing diagnostic accuracy in neuroimaging, cardiovascular care, and oncology. This primer explores the current landscape of pediatric-specific AI tools, highlighting benefits like automated bone age assessment and the critical need for child-centered validation.
Today

Researchers developed a pose-aware deep perceptual metric using contrastive learning to improve 2D/3D registration of knee joints. This AI-driven approach enhances capture range, robustness to noise, and accuracy in joint kinematics analysis for orthopedic procedures.
Today

A large-scale study identifies that alcohol consumption independently elevates highly atherogenic small dense LDL-C (sdLDL-C) levels across steatotic liver disease categories, suggesting a unique cardiovascular risk for MetALD and ALD patients beyond traditional lipid markers.
Today